Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study-Reference-Cited by-同舟云学术

Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study

Published:2021-06 Issue: Volume:Volume 14 Page:609-618
ISSN:1178-6965
Container-title:Journal of Asthma and Allergy
language:en
Short-container-title:JAA

Author:

Numata Takanori^ORCID,Araya Jun,Miyagawa Hanae^ORCID,Okuda Keitaro,Fujita Yu,Utsumi Hirofumi,Takekoshi Daisuke,Hashimoto Mitsuo,Minagawa Shunsuke,Ishikawa Takeo,Hara Hiromichi,Kuwano Kazuyoshi^ORCID

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy

Reference45 articles.

1. WHO. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. 2007:1–146.

2. Time Trend in the Prevalence of Adult Asthma in Japan: Findings from Population-Based Surveys in Fujieda City in 1985,1999, and 2006

3. Japanese guidelines for adult asthma 2017

4. The prevalence of severe refractory asthma

5. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

2. Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort;Allergy;2024-06-22

3. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial;Journal of Allergy and Clinical Immunology;2024-06

4. Long-term safety, durability of response, cessation and switching of biologics;Current Opinion in Pulmonary Medicine;2024-03-01

5. Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study;Journal of Asthma and Allergy;2024-03